Efficacy, Hematologic Effects, And Dose Of Ruxolitinib In Myelofibrosis Patients With Low Starting Platelet Counts (50-100 X 10(9)/L): A Comparison To Patients With Normal Or High Starting Platelet CountsMoshe Talpaz,Ronald Paquette,Lawrence Afrin,Solomon Hamburg,Katarzyna Jamieson,Howard Terebelo,Gregory Ortega,Roger M. Lyons,Ramon V. Tiu,Elliott F. Winton,Kavita Natrajan,Olatoyosi Odenike,Wei Peng,Victor A. Sandor,Peter O'Neill,Sue Erickson-Viitanen,Lance Leopold,Richard S Levy,Hagop M Kantarjian,Srdan VerstovsekBLOOD（2012）引用 9|浏览29暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
